Total Payments
$559.16
2024 Payments
$53.76
Companies
8
Transactions
18
Medicare Patients
4,865
Medicare Billing
$867,119
Payment Breakdown by Category
Consulting$300.00 (53.7%)
Food & Beverage$259.16 (46.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $300.00 | 7 | 53.7% |
| Food and Beverage | $259.16 | 11 | 46.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $300.00 | 7 | $0 (2023) |
| Merz North America, Inc. | $84.56 | 4 | $0 (2018) |
| Allergan Inc. | $75.60 | 1 | $0 (2017) |
| Smith+Nephew, Inc. | $29.59 | 2 | $0 (2024) |
| Acera Surgical, Inc. | $23.92 | 1 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $15.82 | 1 | $0 (2018) |
| Verrica Pharmaceuticals Inc. | $15.45 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $14.22 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53.76 | 3 | Acera Surgical, Inc. ($23.92) |
| 2023 | $140.00 | 3 | Medtronic, Inc. ($140.00) |
| 2022 | $125.20 | 4 | Medtronic, Inc. ($110.00) |
| 2021 | $50.00 | 1 | Medtronic, Inc. ($50.00) |
| 2020 | $14.22 | 1 | Janssen Biotech, Inc. ($14.22) |
| 2018 | $83.18 | 4 | Merz North America, Inc. ($67.36) |
| 2017 | $92.80 | 2 | Allergan Inc. ($75.60) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: DERMATOLOGY | ||||||
| 03/30/2024 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Extra Cellular Matrix | ||||||
| 01/02/2024 | Acera Surgical, Inc. | Restrata Wound Matrix (Device) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Wound Care | ||||||
| 07/19/2023 | Medtronic, Inc. | SURGIPRO LL (Device) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: Wound Closure | ||||||
| 02/16/2023 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| 02/16/2023 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| 12/21/2022 | Medtronic, Inc. | MEROCEL (Device) | Consulting Fee | Cash or cash equivalent | $35.00 | General |
| Category: Dressing, stents and packing | ||||||
| 12/21/2022 | Medtronic, Inc. | MEROCEL (Device) | Consulting Fee | Cash or cash equivalent | $35.00 | General |
| Category: Dressing, stents and packing | ||||||
| 11/10/2022 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| 05/25/2022 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Pharma Products | ||||||
| 08/02/2021 | Medtronic, Inc. | — | Consulting Fee | Cash or cash equivalent | $50.00 | General |
| 01/16/2020 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Immunology | ||||||
| 08/29/2018 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $10.65 | General |
| 07/16/2018 | Ortho Dermatologics, a division of Bausch Health US, LLC | RETIN-A-MICRO (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: DERMATOLOGY | ||||||
| 05/17/2018 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.48 | General |
| 05/02/2018 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $32.23 | General |
| 04/28/2017 | MERZ NORTH AMERICA, INC. | — | Food and Beverage | Cash or cash equivalent | $17.20 | General |
| 03/09/2017 | Allergan Inc. | NATRELLE 410 IMPLANTS (Device) | Food and Beverage | In-kind items and services | $75.60 | General |
| Category: PLASTICS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,292 | 1,811 | $328,221 | $194,475 |
| 2022 | 27 | 1,288 | 1,721 | $364,584 | $225,244 |
| 2021 | 31 | 1,235 | 1,572 | $384,436 | $241,490 |
| 2020 | 28 | 1,050 | 1,261 | $324,546 | $205,910 |
Total Patients
4,865
Total Services
6,365
Medicare Billing
$867,119
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 70 | 72 | $35,020 | $25,555 | 73.0% |
| 13131 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 1.1-2.5 cm | Office | 2023 | 83 | 87 | $33,797 | $23,710 | 70.2% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 64 | 76 | $32,361 | $23,702 | 73.2% |
| 13151 | Complicated repair of wound of eyelids, nose, ears, or lip, 1.1-2.5 cm | Office | 2023 | 60 | 64 | $27,916 | $20,454 | 73.3% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 110 | 129 | $34,761 | $13,309 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 177 | 254 | $18,944 | $13,182 | 69.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 33 | 41 | $16,246 | $11,019 | 67.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 118 | 138 | $14,186 | $7,853 | 55.4% |
| 13120 | Complicated repair of wound of scalp, arms, or legs, 1.1-2.5 cm | Office | 2023 | 27 | 27 | $9,594 | $7,115 | 74.2% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 42 | 57 | $15,926 | $6,088 | 38.2% |
| 11643 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 2.1-3.0 cm | Office | 2023 | 40 | 42 | $13,351 | $5,300 | 39.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 100 | 131 | $8,567 | $4,560 | 53.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 43 | 51 | $5,686 | $3,874 | 68.1% |
| 13100 | Complicated repair of wound of trunk, 1.1-2.5 cm | Office | 2023 | 14 | 14 | $4,770 | $3,529 | 74.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 29 | 37 | $6,504 | $3,183 | 48.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 30 | $7,293 | $2,678 | 36.7% |
| 11604 | Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm | Office | 2023 | 23 | 23 | $7,170 | $2,579 | 36.0% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 26 | 26 | $6,560 | $2,383 | 36.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 38 | 63 | $3,207 | $2,309 | 72.0% |
| 11644 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 3.1-4.0 cm | Office | 2023 | 15 | 15 | $5,910 | $2,140 | 36.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 15 | 18 | $3,076 | $2,117 | 68.8% |
| 11623 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 2.1-3.0 cm | Office | 2023 | 15 | 15 | $4,458 | $1,857 | 41.7% |
| 11641 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 21 | 22 | $5,265 | $1,664 | 31.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 61 | 336 | $2,120 | $1,618 | 76.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $1,506 | $1,017 | 67.5% |
About Dr. Christopher Savage, MD
Dr. Christopher Savage, MD is a Plastic Surgery within the Head & Neck healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1225239072.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Savage, MD has received a total of $559.16 in payments from pharmaceutical and medical device companies, with $53.76 received in 2024. These payments were reported across 18 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($300.00).
As a Medicare-enrolled provider, Savage has provided services to 4,865 Medicare beneficiaries, totaling 6,365 services with total Medicare billing of $867,119. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Plastic Surgery within the Head & Neck
- Other Specialties Facial Plastic Surgery
- Location Orlando, FL
- Active Since 05/30/2007
- Last Updated 01/21/2025
- Taxonomy Code 207YX0007X
- Entity Type Individual
- NPI Number 1225239072
Products in Payments
- NATRELLE 410 IMPLANTS (Device) $75.60
- MEROCEL (Device) $70.00
- SURGIPRO LL (Device) $40.00
- Restrata Wound Matrix (Device) $23.92
- RETIN-A-MICRO (Drug) $15.82
- YCANTH (Drug) $15.45
- COLLAGENASE SANTYL (Drug) $15.20
- STRAVIX PL (Medical Supply) $14.39
- TREMFYA (Drug) $14.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.